In this study, researchers calculated a national estimate of lung cancer screening-eligible individuals, including estimates based on demographic variables and geographic regions.

The application for the next-generation mitomycin formulation is supported by 3-month complete response data from the phase 3 UTOPIA trial.

New ACOG guidance says benefits outweigh risks for most women, with nonhormonal options for those who can’t take hormones ...

In this analysis, researchers examined the association of quality of life and functional outcomes with organ preservation following total neoadjuvant treatment among patients with rectal cancer.

In the LIGHT trial, researchers compared carbon dioxide laser therapy and sham laser therapy for breast cancer survivors receiving AIs who presented with GSM and dyspareunia.

Inverse correlation reported for pathogenic variant prevalence with age at diagnosis, but prevalence was 12.3 percent in late-onset tumors ...

A Massachusetts man has admitted to helping launder money from a scheme that billed Medicare more than $6 million for knee and back braces patients didn’t need or ask for. Leo Anzivino Jr., 35, of ...

In this cohort study, researchers evaluated associations between ultra-processed foods and dietary factors linked to colorectal cancer.

In this study, researchers aimed to analyze the effect of communicating uncertainties about the benefits and risks of new cancer drugs on patients’ decision to take the drug.

A qualitative study explored how the relationship between oncology and palliative care teams influences end-of-life care for patients with cancer.

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

Kiran K. Chauhan, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues reported use of MBRT for patients with superficial cutaneous and soft tissue malignancies from a single institution. A ...